Literature DB >> 17126019

Design and study of some novel ibuprofen derivatives with potential nootropic and neuroprotective properties.

Ioanna C Siskou1, Eleni A Rekka, Angeliki P Kourounakis, Michael C Chrysselis, Kariofyllis Tsiakitzis, Panos N Kourounakis.   

Abstract

Six novel ibuprofen derivatives and related structures, incorporating a proline moiety and designed for neurodegenerative disorders, are studied. They possess anti-inflammatory properties and three of them inhibited lipoxygenase. One compound was found to inhibit cyclooxygenase (COX)-2 production in spleenocytes from arthritic rats. The HS-containing compounds are potent antioxidants and one of them protected against glutathione loss after cerebral ischemia/reperfusion. They demonstrated lipid-lowering ability and seem to acquire low gastrointestinal toxicity. Acetylcholinesterase inhibitory activity, found in two of these compounds, may be an asset to their actions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126019     DOI: 10.1016/j.bmc.2006.10.056

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  In vitro and in vivo investigation of dexibuprofen derivatives for CNS delivery.

Authors:  Xuan Zhang; Xing Liu; Tao Gong; Xun Sun; Zhi-rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

3.  Conjugates of urolithin A with NSAIDs, their stability, cytotoxicity, and anti-inflammatory potential.

Authors:  Maciej Korczak; Piotr Roszkowski; Sebastian Granica; Jakub P Piwowarski
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

4.  Synthesis and characterization of NIR-responsive Aurod@pNIPAAm-PEGMA nanogels as vehicles for delivery of photodynamic therapy agents.

Authors:  Ting Shang; Cai-Ding Wang; Lei Ren; Xin-Hua Tian; Dong-Hui Li; Xue-Bin Ke; Min Chen; An-Qi Yang
Journal:  Nanoscale Res Lett       Date:  2013-01-02       Impact factor: 4.703

5.  Nanoprodrugs of NSAIDs: Preparation and Characterization of Flufenamic Acid Nanoprodrugs.

Authors:  Bong-Seop Lee; Chi Woo Yoon; Arsen Osipov; Nuriel Moghavem; Daniel Nwachokor; Rina Amatya; Rebekah Na; Joe L Pantoja; Michael D Pham; Keith L Black; John S Yu
Journal:  J Drug Deliv       Date:  2011-04-05

6.  Influence of the Type of Amino Acid on the Permeability and Properties of Ibuprofenates of Isopropyl Amino Acid Esters.

Authors:  Paula Ossowicz-Rupniewska; Joanna Klebeko; Ewelina Świątek; Karolina Bilska; Anna Nowak; Wiktoria Duchnik; Łukasz Kucharski; Łukasz Struk; Karolina Wenelska; Adam Klimowicz; Ewa Janus
Journal:  Int J Mol Sci       Date:  2022-04-09       Impact factor: 6.208

7.  Enhancement of the Anti-Inflammatory Activity of NSAIDs by Their Conjugation with 3,4,5-Trimethoxybenzyl Alcohol.

Authors:  Paraskevi Tziona; Panagiotis Theodosis-Nobelos; Georgios Papagiouvannis; Anthi Petrou; Chryssoula Drouza; Eleni A Rekka
Journal:  Molecules       Date:  2022-03-24       Impact factor: 4.411

8.  Reactive oxygen species-activated nanoprodrug of Ibuprofen for targeting traumatic brain injury in mice.

Authors:  Morgan A Clond; Bong-Seop Lee; Jeffrey J Yu; Matthew B Singer; Takayuki Amano; Alexander W Lamb; Doniel Drazin; Babak Kateb; Eric J Ley; John S Yu
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

9.  Anti-inflammatory activity and PGE2 inhibitory properties of novel phenylcarbamoylmethyl ester-containing compounds.

Authors:  Flora Barsoum; Hanan Georgey; Nagwa Abdel-Gawad
Journal:  Molecules       Date:  2009-02-11       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.